BARRON’S MAGAZINE: The latest issue features ‘The Next Berkshire’…
Berkshire Hathaway Wannabes Are Coming. We Sized Up the Contenders.
These companies are seeking to replicate Warren Buffett’s formula as he prepares to retire. Some have been big winners.
Why the Trump Feud Won’t Push Musk Out as Tesla CEO
“Tesla without Musk would be a disaster for Tesla shareholders,” a longtime Tesla bull told Barron’s.
A Stablecoin IPO Soars and Bitcoin Keeps Climbing. Great Crypto Plays for Right Now.
This week’s blockbuster IPO of Circle, a leading issuer of stablecoins, shows how crypto is increasingly going mainstream. Here’s how to invest.
Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments
U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be worth up to $25 billion.
Boomers Daily 